The Impact of HLA Alleles on the Severity of COVID-19 in Kidney Transplant Patientss.

The Impact of HLA Alleles on the Severity of COVID-19 in Kidney Transplant Patientss.

Publication date: Sep 16, 2025

Human Leukocyte Antigen (HLA) genes play a crucial role in immune response against infectious disease. In this study, we aimed to investigate the frequency of HLA alleles in kidney transplant patients diagnosed with COVID-19 and explore potential associations with disease severity. Kidney transplant patients who were diagnosed with COVID-19 and followed up at the Istanbul Medical Faculty Hospital kidney transplant clinic between March 2020 and January 2023 were included in this study. All patients were genotyped for HLA loci (HLA-A,-B,-DRB1) at low resolution using the Luminex method. Patients were classified as mild, moderate, and severe according to COVID-19 severity. In a study of 332 kidney transplant patients, 52 developed severe COVID-19, with 24 deaths. Severe cases were older and had higher rates of hospitalization, Intensive Care Unit (ICU) admissions, acute kidney injury, and mortality (all P

Concepts Keywords
Allele Admissions
Hospitalization Alleles
Istanbul Covid
January Diagnosed
Kidney Disease
Drb1
Higher
Hla
Hospital
Icu
Kidney
Severe
Severity
Study
Transplant

Semantics

Type Source Name
disease MESH COVID-19
disease IDO role
disease IDO immune response
disease MESH infectious disease
pathway REACTOME Infectious disease
disease MESH acute kidney injury
disease MESH cardiovascular disease
disease IDO susceptibility
disease MESH infection
disease MESH Long Covid

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *